Todd Brady Ph.D Overview

  • Primary Position
  • Chief Executive...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 4

  • Med. Deal Size

  • Med. Valuation

Todd Brady Ph.D General Information

Biography

Dr. Todd Brady serves as Independent Director at Evoke Pharma. He served as Director at Outlook Therapeutic. He served as Chief Executive Officer, President & Board Member at Aldeyra Therapeutics. He served as Advisor at Sebacia. He served as Board Member at F-Star Therapeutics. He was an entrepreneur-in-residence and principal at Domain Associates, where he led institutional financing in numerous biotechnology companies from 2004 to 2013. Prior to joining Domain, He co-founded and served as CEO of Phenome Sciences, a biotechnology firm he merged with Xanthus Pharmaceuticals (acquired by Antisoma), where he was later executive vice president of Strategic Development and Planning. He also worked as head of business development and medical director at Aderis Pharmaceuticals (acquired by Schwarz Pharma, now part of UCB). While at Xanthus and Aderis, he was a medical consultant on numerous pre-clinical programs and clinical programs in Phases I through IV, including Neupro®, a drug now marketed for Parkinson's Disease. He holds an M.D. from Duke University Medical School, a Ph.D. from Duke University Graduate School, and an A.B. from Dartmouth College.

Contact Information

Primary Position
Chief Executive Officer, President & Board Member, Aldeyra Therapeutics
Education
Duke University, Ph.D. (Doctor of Philosophy)
Duke University, MD (Doctor of Medicine)
Dartmouth College, BA (Bachelor of Arts)
Gender
Male
Email
tb
Phone
+1 (781)
Address
  • 131 Hartwell Avenue
  • Suite 320
  • Lexington, MA 02421
  • United States
+1 (781)

Todd Brady Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
Aldeyra Therapeutics Company Chief Executive Officer, President & Board Member Lexington, MA Drug Discovery

Todd Brady Ph.D Board Seats (4)

Company Industry Ownership Status Financing Status Location Since
Aldeyra Therapeutics Drug Discovery Publicly Held Formerly VC-backed Lexington, MA
Cantex Pharmaceuticals Pharmaceuticals Privately Held (backing) Formerly VC-backed Weston, FL
Evoke Pharma Pharmaceuticals Publicly Held Formerly VC-backed Solana Beach, CA
Outlook Therapeutics Drug Discovery Publicly Held Formerly VC-backed Iselin, NJ

Todd Brady Ph.D Lead Partner on Deals (9)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Helio Vision 28-Jan-2019 Merger/Acquisition Completed Drug Discovery Waltham, MA
Aldeyra Therapeutics 01-Aug-2013 Completed Drug Discovery Lexington, MA
Cantex Pharmaceuticals 04-Aug-2010 Completed Pharmaceuticals Weston, FL
Aldeyra Therapeutics 01-Apr-2010 Completed Drug Discovery Lexington, MA
Aldeyra Therapeutics 11-Aug-2008 Completed Drug Discovery Lexington, MA
Cantex Pharmaceuticals 13-Aug-2007 Completed Pharmaceuticals Weston, FL
Asmacure 08-May-2007 Completed Drug Delivery Pointe-Claire, Canada
Cantex Pharmaceuticals 25-Aug-2006 Early Stage VC (Series B) Completed Pharmaceuticals Weston, FL
Aldeyra Therapeutics 30-Sep-2005 Seed Round Completed Drug Discovery Lexington, MA

Todd Brady Ph.D Network (97)

Board Members (62)

Name Company Representing Location From
Kurt Hilzinger Outlook Therapeutics Self Iselin, NJ
John Edwards F-Star Therapeutics Self Cambridge, United Kingdom
Cantex Pharmaceuticals The Aurora Funds Weston, FL
F-Star Therapeutics Novo Holdings Cambridge, United Kingdom
Outlook Therapeutics Outlook Therapeutics Iselin, NJ

Portfolio Executives (25)

Name Company Role Deal date Location
Michael Aceti Helio Vision Chief Financial Officer & Chief Business Officer 28-Jan-2019 Waltham, MA
Kelly Mizer Aldeyra Therapeutics Vice President, Commercial Strategy and Operations 01-Aug-2013 Lexington, MA
Aldeyra Therapeutics Chief Medical Officer 01-Aug-2013 Lexington, MA
Aldeyra Therapeutics Chief Operating Officer 01-Aug-2013 Lexington, MA
Aldeyra Therapeutics Chief Development Officer 01-Aug-2013 Lexington, MA

Fund Team Members (10)

Name Investor Fund Fund Location
Brian Dovey Domain Associates Domain Partners VI Princeton, NJ
Brian Dovey Domain Associates Domain Partners VII Princeton, NJ
Domain Associates Princeton, NJ
Domain Associates Princeton, NJ
Domain Associates Princeton, NJ

Todd Brady Ph.D Affiliated Funds (3)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Domain Partners VIII Domain Associates Venture - General Closed 2009
Domain Partners VI Domain Associates Venture - General Closed 2001
Domain Partners VII Domain Associates Venture - General Closed 2006

Todd Brady Ph.D FAQs

  • Who is Todd Brady Ph.D?

    Dr. Todd Brady serves as Independent Director at Evoke Pharma.

  • How much does Todd Brady Ph.D typically invest?

    Todd Brady Ph.D's median deal size is .

  • What is Todd Brady Ph.D’s main position?

    Todd Brady Ph.D’s primary position is Chief Executive Officer, President & Board Member.

  • What are the contact details for Todd Brady Ph.D?

    Todd Brady Ph.D’s email address is tb and his phone number is +1 (781) .

  • How many active board seats does Todd Brady Ph.D hold?

    Todd Brady Ph.D holds 4 board seats including Aldeyra Therapeutics, Cantex Pharmaceuticals, Evoke Pharma, and Outlook Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »